Showing results (331-340 of 388) with videos related to

Sort By:
Pageof 39
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2013
The CYP2B6*6 allele significantly alters the N-demethylation of ketamine enantiomers in vitroYibai Li, Janet K Coller, Mark R Hutchinson, et al.
Geroscience|May 20, 2020
Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from HungaryGábor Kemenesi, László Kornya, Gábor Endre Tóth, et al.
Pharmacogenetics and Genomics|September 28, 2011
OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependenceJanet K Coller, Sharon Cahill, Carolyn Edmonds, et al.
Journal of Psychopharmacology (Oxford, England)|March 16, 2018
Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trialVerònica Gálvez, Adrienne Li, Christina Huggins, et al.
Journal of Sleep Research|December 15, 2020
The effect of acute morphine on sleep in male patients suffering from sleep apnea: Is there a genetic effect? An RCT StudyLuke Rowsell, Justin Guang-Ao Wu, Brendon J Yee, et al.
Therapeutic Drug Monitoring|November 23, 2011
Measurement of cyclosporine A in rat tissues and human kidney transplant biopsies--a method suitable for small (<1 mg) samplesBenjamin D Noll, Janet K Coller, Andrew A Somogyi, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineBenjamin J L Davies, Janet K Coller, Heather M James, et al.
Therapeutic Drug Monitoring|August 8, 2013
Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesBenjamin D Noll, Janet K Coller, Andrew A Somogyi, et al.
Pageof 39